# Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

> **NCT02462070** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 203 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** IDP-118 Lotion
- **DRUG:** IDP-118 Vehicle Lotion

## Key facts

- **NCT ID:** NCT02462070
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-11
- **Primary completion:** 2016-11-08
- **Final completion:** 2016-12-01
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2020-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02462070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02462070, "Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02462070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*